Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATHFNDR-2 phase 3 trial of paltusotine versus placebo in acromegaly
MOH_2022-12-12_012230Phase 3Not yet recruiting
- Sponsor
- Crinetics Pharmaceuticals
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acromegaly comparing Paltusotine with Placebo (2 arms). Planned start Nov 2022; status: not yet recruiting.
02
Drugs
paltusotine
03
Conditions
acromegaly
Beyond the preview
Go deeper on MOH_2022-12-12_012230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-12-12_012230.